Oppenheimer Asset Management Inc. Ideaya Biosciences, Inc. Transaction History
Oppenheimer Asset Management Inc.
- $8.04 Billion
- Q3 2024
A detailed history of Oppenheimer Asset Management Inc. transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Oppenheimer Asset Management Inc. holds 12,058 shares of IDYA stock, worth $321,466. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,058
Previous 12,213
1.27%
Holding current value
$321,466
Previous $428,000
10.98%
% of portfolio
0.0%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding IDYA
# of Institutions
216Shares Held
80.8MCall Options Held
69KPut Options Held
20K-
Black Rock Inc. New York, NY6.81MShares$181 Million0.01% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA5.21MShares$139 Million0.38% of portfolio
-
Janus Henderson Group PLC London, X05.16MShares$138 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.8MShares$128 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.02MShares$107 Million0.01% of portfolio
About IDEAYA Biosciences, Inc.
- Ticker IDYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,067,700
- Market Cap $1.28B
- Description
- IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...